News
Leerink Partners analyst Michael Cherny reiterated a Hold rating on Certara (CERT – Research Report) on April 11. The company’s shares closed ...
Leerink Partners analyst Michael Cherny maintained a Hold rating on Envista Holdings (NVST – Research Report) on April 10 and set a price ...
7d
Fintel on MSNLeerink Partners Initiates Coverage of Spyre Therapeutics (SYRE) with Outperform RecommendationFintel reports that on April 8, 2025, Leerink Partners initiated coverage of Spyre Therapeutics (NasdaqGS:SYRE) with a ...
Investment analysts at Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for shares of Quest ...
Hosted on MSN18d
Leerink Partners Downgrades Equillium (EQ)Fintel reports that on March 28, 2025, Leerink Partners downgraded their outlook for Equillium (NasdaqCM:EQ) from Outperform to Market Perform. Analyst Price Forecast Suggests 736.07% Upside As of ...
Fintel reports that on March 28, 2025, Leerink Partners downgraded their outlook for Equillium (LSE:0A4D) from Outperform to Market Perform. There are 35 funds or institutions reporting positions ...
Some are about to move in with their partners. Others are deciding if they should have kids. Doing loyalty tests "can be a little triggering sometimes," Ari says, reminding her of when she was cheated ...
Easily identify stocks' risks and opportunities. Discover stocks' market position with detailed competitor analyses. According to TipRanks, Risinger is a 5-star analyst with an average return of 9 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results